{
    "clinical_study": {
        "@rank": "10146", 
        "biospec_descr": {
            "textblock": "DNA from blood and skin and muscle biopsy samples."
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "OBJECTIVES: I.  Clinically evaluate members from families with a dominantly inherited ataxia\n      and collect blood, skin and muscle samples for detailed molecular studies.\n\n      II.  Perform detailed clinical evaluations on patients with recessively inherited ataxias."
        }, 
        "brief_title": "Clinical and Molecular Correlations in Spinocerebellar Ataxia Type 10 (SCA10)", 
        "completion_date": {
            "#text": "March 2009", 
            "@type": "Actual"
        }, 
        "condition": "Hereditary Ataxia", 
        "condition_browse": {
            "mesh_term": [
                "Ataxia", 
                "Spinocerebellar Degenerations", 
                "Spinocerebellar Ataxias"
            ]
        }, 
        "detailed_description": {
            "textblock": "PROTOCOL OUTLINE: Participants undergo a comprehensive clinical and molecular evaluation.\n      Studies include:  neurologic evaluation, including magnetic resonance imaging and nerve\n      conduction studies; ophthalmologic exam; audiologic exam, including auditory brain stem\n      evoked response; DNA extraction from blood, skin and muscle; genotype phenotype correlation.\n\n      A neuropathologic evaluation is conducted postmortem, when possible."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion criteria:\n\n        Subjects who have the diagnosis of SCA10 and their immediate relatives.\n\n        Exclusion criteria:\n\n        Children under 3 years of age, pregnant women, prisoners, mentally incapacitated subjects,\n        and subjects who do not give consent."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "3 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients with inherited ataxia"
            }
        }, 
        "enrollment": {
            "#text": "18", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 18, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00004306", 
            "org_study_id": "199/11796"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "hereditary ataxia", 
            "neurologic and psychiatric disorders", 
            "rare disease"
        ], 
        "lastchanged_date": "March 5, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Galveston", 
                    "country": "United States", 
                    "state": "Texas", 
                    "zip": "77555"
                }, 
                "name": "University of Texas Medical Branch at Galveston"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Pathogenic Mechanism of Spinocerebellar Ataxia Type 10 (SCA10)", 
        "overall_official": {
            "affiliation": "University of Texas, Galveston", 
            "last_name": "Tetsuo Ashizawa, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2009", 
            "@type": "Actual"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00004306"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Office of Rare Diseases (ORD)", 
            "investigator_full_name": "Tetsuo Ashizawa", 
            "investigator_title": "Professor and Chair, Department of Neurology, The University of Texas Medical Branch", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Office of Rare Diseases (ORD)", 
        "sponsors": {
            "collaborator": {
                "agency": "The University of Texas, Galveston", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Office of Rare Diseases (ORD)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "November 1999", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "March 2012"
    }, 
    "geocoordinates": {
        "University of Texas Medical Branch at Galveston": "29.301 -94.798"
    }
}